Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

Positive Regulator Molecules

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

High Theta (4-10 Hz) power as a biomarker of inhibition during epileptogenesis in an animal model of mesial temporal lobe epilepsy.

Experimental neurology·2026

Same author

Influence of the estrous cycle on seizure activity in a model of mesial temporal lobe epilepsy.

Experimental neurology·2025

Same author

Spreading depolarization and its influence on epileptiform activity.

Epilepsia·2025

Same author

Interneurons, GABA<sub>A</sub> signaling and their presumptive role in catamenial epilepsy.

Neuroscience and biobehavioral reviews·2025

Same author

Modulation of <i>in vitro</i> Network Activity by Optogenetic Stimulation of Parvalbumin-positive Interneurons During Estrous Cycle.

Current neuropharmacology·2025

Same author

Fast activity chirp patterns in focal seizures from patients and animal models.

Epilepsia·2024

Same journal

Loss of immunological control at CD28 superfamily checkpoints links brain and peripheral immunity to depressive-like behaviors in animal models.

Neurobiology of disease·2026

Same journal

Investigating tau-related white matter degeneration in Alzheimer's disease using fixel-based analysis.

Neurobiology of disease·2026

Same journal

Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease.

Neurobiology of disease·2026

Same journal

Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.

Neurobiology of disease·2026

Same journal

GDAP1 orchestrates redox signaling at membrane contact sites to preserve axonal integrity in Charcot-Marie-Tooth disease.

Neurobiology of disease·2026

Same journal

Tier-specific location of Lewy body pathology and related neuromelanin levels drive dopaminergic cell vulnerability in pigmented non-human primates.

Neurobiology of disease·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 13, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

KCC2 function modulates in vitro ictogenesis.

Shabnam Hamidi¹, Massimo Avoli¹

¹Montreal Neurological Institute and Department of Neurology & Neurosurgery, McGill University, 3801 University Street, Montréal, QC, Canada H3A 2B4 McGill University, 3801 University Street, Montréal, QC, Canada, H3A 2B4.

Neurobiology of Disease

|May 1, 2015

Summary

This summary is machine-generated.

The KCC2 transporter plays a crucial role in regulating brain inhibition and epilepsy. Inhibiting KCC2 activity stops seizure-like activity, while enhancing it prolongs it, offering potential therapeutic targets for epilepsy.

Keywords:

4-Aminopyridine Entorhinal cortex Epilepsy GABA High-frequency oscillations KCC2 NKCC1 Piriform cortex

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Related Experiment Videos

Last Updated: Apr 13, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Area of Science:

Neuroscience
Epilepsy Research
Cellular Physiology

Background:

GABAA receptor-mediated inhibition is vital for preventing epileptiform synchronization.
The efficacy of GABAA inhibition depends on low intracellular chloride levels, maintained by KCC2 transporter activity.

Purpose of the Study:

To investigate the role of KCC2 activity in modulating epileptiform discharges in the piriform and entorhinal cortices.
To determine the effects of KCC2 blockers and enhancers on seizure-like activity in an in vitro brain slice model.

Main Methods:

Field potential recordings were used to analyze epileptiform discharges in brain slices.
The effects of KCC2 blockers (VU0240551, bumetanide) and an enhancer (CLP257) were examined.
Epileptiform activity was induced using 4-aminopyridine (4AP).

Main Results:

Blocking KCC2 activity abolished ictal discharges and reduced interictal discharges in the piriform and entorhinal cortices.
Enhancing KCC2 activity increased the duration of ictal discharges.
KCC2 activity modulation affected the duration and amplitude of synchronous GABAergic events.

Conclusions:

KCC2 activity significantly influences in vitro ictogenesis, with inhibition abolishing and enhancement facilitating seizure activity.
Modulating KCC2 function may represent a novel therapeutic strategy for epilepsy.
The observed effects are likely related to KCC2's role in regulating extracellular potassium levels during GABAA receptor activation.